• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

podcast

Podcast
Graphic for the Podnosis podcast by Fierce featuring a stylized heart at the center surrounded by colorful sound wave visual
Podcast

When drug development gets personal

A brain cancer diagnosis changed how one biotech investor thinks about the patient experience. He shares his story on "The Top Line."
Ayla Ellison , Will Maddox Oct 30, 2026 9:28am
Podcast
Fierce 15

How we picked the Fierce 15

Oct 9, 2026 7:21am
Podcast
Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b

Inside the growing world of biopharma prediction markets

Sep 18, 2026 9:39am
Podcast
Promotional graphic for The Top Line featuring a microscope molecular model and laboratory glassware against a blue gr

The future of RAS inhibitors

Sep 11, 2026 9:48am
Podcast
The Top Line TTL 2023

Novo Nordisk’s CFO on the oral Wegovy rollout and beyond

Aug 7, 2026 8:42am
Podcast
Promotional graphic for The Top Line featuring a microscope molecular model and laboratory glassware against a blue gr

5 emerging biotech hubs

Jul 17, 2026 9:18am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings